Lei Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lei Sun has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
Qiuzhong Zhou
Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore, Singapore
7 shared publicationsYen Ching Lim
Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore
6 shared publications- Arcinas Camille Esther Walet
Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore
5 shared publications Dan Xu
The Hormel Institute, University of Minnesota, Austin, MN, USA
5 shared publicationsKinyui Alice Lo
Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore, 138673, Singapore
5 shared publications- Peng Chen
Nanyang Technological University
5 shared publications
Latest Publications
- 2 October 2026
- Published by Elsevier in Trends in Endocrinology & Metabolism
Isoform usage dynamics in metabolic adaptation
- 2 October 2026
- Published by Elsevier in Trends in Endocrinology & Metabolism
Isoform usage dynamics in metabolic adaptation
- Open Access
- 24 January 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
FAST: Scalable Factor Analysis for Spatial Dimension Reduction of Multi-section Spatial Transcriptomics
Biological techniques for spatially resolved transcriptomics (SRT) have advanced rapidly in both throughput and spatial resolution. This progress calls for efficient and scalable spatial dimension reduction methods capable of handling large-scale SRT data from multiple tissue sections. Here, we developed FAST, a fast and efficient generalized probabilistic factor analysis model for spatially aware dimension reduction. FAST simultaneously accounts for the count-based nature of SRT data and extracts low-dimensional representations across multiple sections, while preserving biological signals and incorporating spatial smoothness among neighboring locations. Unlike existing methods, FAST explicitly models count data across sections and leverages local spatial dependencies with scalable computational complexity. Using both simulated and real datasets, we demonstrated that embeddings estimated by FAST show improved correlation with annotated cell and domain types. Notably, FAST was the only method capable of analyzing a mouse embryo Stereo-seq dataset with > 2.3 million spatial locations in just 2 hours. FAST also identified differential activity of immune-related transcription factors between tumor and non-tumor clusters and predicted the carcinogenesis factor CCNH as an upstream regulator of differentially expressed genes in a breast cancer Xenium dataset. FAST is available for non-commercial use at https://github.com/feiyoung/ProFAST.
- 24 January 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessFAST: Scalable Factor Analysis for Spatial Dimension Reduction of Multi-section Spatial Transcriptomics
Biological techniques for spatially resolved transcriptomics (SRT) have advanced rapidly in both throughput and spatial resolution. This progress calls for efficient and scalable spatial dimension reduction methods capable of handling large-scale SRT data from multiple tissue sections. Here, we developed FAST, a fast and efficient generalized probabilistic factor analysis model for spatially aware dimension reduction. FAST simultaneously accounts for the count-based nature of SRT data and extracts low-dimensional representations across multiple sections, while preserving biological signals and incorporating spatial smoothness among neighboring locations. Unlike existing methods, FAST explicitly models count data across sections and leverages local spatial dependencies with scalable computational complexity. Using both simulated and real datasets, we demonstrated that embeddings estimated by FAST show improved correlation with annotated cell and domain types. Notably, FAST was the only method capable of analyzing a mouse embryo Stereo-seq dataset with > 2.3 million spatial locations in just 2 hours. FAST also identified differential activity of immune-related transcription factors between tumor and non-tumor clusters and predicted the carcinogenesis factor CCNH as an upstream regulator of differentially expressed genes in a breast cancer Xenium dataset. FAST is available for non-commercial use at https://github.com/feiyoung/ProFAST.
- 11 February 2025
- Published by Elsevier in Cell Metabolism
- Vol. 37 (3) , 772-787.e6
Isoform usage as a distinct regulatory layer driving nutrient-responsive metabolic adaptation
- 11 February 2025
- Published by Elsevier in Cell Metabolism
- Vol. 37 (3) , 772-787.e6
Isoform usage as a distinct regulatory layer driving nutrient-responsive metabolic adaptation
- 24 August 2023
- Published by Elsevier in Cell Metabolism
- Vol. 35 (9) , 1661-1671.e6
Deciphering the decline of metabolic elasticity in aging and obesity
- 24 August 2023
- Published by Elsevier in Cell Metabolism
- Vol. 35 (9) , 1661-1671.e6
Deciphering the decline of metabolic elasticity in aging and obesity
- Open Access
- 12 May 2023
- Published by Elsevier in Molecules and Cells
- Vol. 46 (5) , 268-277
The Role of Splicing Factors in Adipogenesis and Thermogenesis
Yadanar Than Naing and Lei Sun. Mol. Cells 2023;46:268-77. https://doi.org/10.14348/molcells.2023.2195
- 12 May 2023
- Published by Elsevier in Molecules and Cells
- Vol. 46 (5) , 268-277
Open AccessThe Role of Splicing Factors in Adipogenesis and Thermogenesis
Yadanar Than Naing and Lei Sun. Mol. Cells 2023;46:268-77. https://doi.org/10.14348/molcells.2023.2195
- Open Access
- 5 April 2023
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 6 (6) , e202302002
Multidimensional conservation analysis decodes the expression of conserved long noncoding RNAs
Although long noncoding RNAs (lncRNAs) experience weaker evolutionary constraints and exhibit lower sequence conservation than coding genes, they can still conserve their features in various aspects. Here, we used multiple approaches to systemically evaluate the conservation between human and mouse lncRNAs from various dimensions including sequences, promoter, global synteny, and local synteny, which led to the identification of 1,731 conserved lncRNAs with 427 high-confidence ones meeting multiple criteria. Conserved lncRNAs, compared with non-conserved ones, generally have longer gene bodies, more exons and transcripts, stronger connections with human diseases, and are more abundant and widespread across different tissues. Transcription factor (TF) profile analysis revealed a significant enrichment of TF types and numbers in the promoters of conserved lncRNAs. We further identified a set of TFs that preferentially bind to conserved lncRNAs and exert stronger regulation on conserved than non-conserved lncRNAs. Our study has reconciled some discrepant interpretations of lncRNA conservation and revealed a new set of transcriptional factors ruling the expression of conserved lncRNAs.
- 5 April 2023
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 6 (6) , e202302002
Open AccessMultidimensional conservation analysis decodes the expression of conserved long noncoding RNAs
Although long noncoding RNAs (lncRNAs) experience weaker evolutionary constraints and exhibit lower sequence conservation than coding genes, they can still conserve their features in various aspects. Here, we used multiple approaches to systemically evaluate the conservation between human and mouse lncRNAs from various dimensions including sequences, promoter, global synteny, and local synteny, which led to the identification of 1,731 conserved lncRNAs with 427 high-confidence ones meeting multiple criteria. Conserved lncRNAs, compared with non-conserved ones, generally have longer gene bodies, more exons and transcripts, stronger connections with human diseases, and are more abundant and widespread across different tissues. Transcription factor (TF) profile analysis revealed a significant enrichment of TF types and numbers in the promoters of conserved lncRNAs. We further identified a set of TFs that preferentially bind to conserved lncRNAs and exert stronger regulation on conserved than non-conserved lncRNAs. Our study has reconciled some discrepant interpretations of lncRNA conservation and revealed a new set of transcriptional factors ruling the expression of conserved lncRNAs.
- Open Access
- 3 November 2022
- Published by Oxford University Press (OUP) in Life Metabolism
- Vol. 1 (3) , 201-202
WTAP: a new player in postnatal BAT development
- 3 November 2022
- Published by Oxford University Press (OUP) in Life Metabolism
- Vol. 1 (3) , 201-202
Open AccessWTAP: a new player in postnatal BAT development
- 21 September 2022
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 18 (11) , 663-664
HOTAIR underlies the region-specific development of adipose tissue
- 21 September 2022
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 18 (11) , 663-664
HOTAIR underlies the region-specific development of adipose tissue
- Open Access
- 22 June 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells
Background: Marrow adipose tissue (MAT) has been shown to be vital for regulating metabolism and maintaining skeletal homeostasis in the bone marrow (BM) niche. As a reflection of BM remodeling, MAT is highly responsive to nutrient fluctuations, hormonal changes, and metabolic disturbances such as obesity and diabetes mellitus. Expansion of MAT has also been strongly associated with bone loss in mice and humans. However, the regulation of BM plasticity remains poorly understood, as does the mechanism that links changes in marrow adiposity with bone remodeling.Methods: We studied deletion of Adipsin, and its downstream effector, C3, in C57BL/6 mice as well as the bone-protected PPARγ constitutive deacetylation 2KR mice to assess BM plasticity. The mice were challenged with thiazolidinedione treatment, calorie restriction, or aging to induce bone loss and MAT expansion. Analysis of bone mineral density and marrow adiposity was performed using a μCT scanner and by RNA analysis to assess adipocyte and osteoblast markers. For in vitro studies, primary bone marrow stromal cells were isolated and subjected to osteoblastogenic or adipogenic differentiation or chemical treatment followed by morphological and molecular analyses. Clinical data was obtained from samples of a previous clinical trial of fasting and high-calorie diet in healthy human volunteers.Results: We show that Adipsin is the most upregulated adipokine during MAT expansion in mice and humans in a PPARγ acetylation-dependent manner. Genetic ablation of Adipsin in mice specifically inhibited MAT expansion but not peripheral adipose depots, and improved bone mass during calorie restriction, thiazolidinedione treatment, and aging. These effects were mediated through its downstream effector, complement component C3, to prime common progenitor cells toward adipogenesis rather than osteoblastogenesis through inhibiting Wnt/β-catenin signaling.Conclusions: Adipsin promotes new adipocyte formation and affects skeletal remodeling in the BM niche. Our study reveals a novel mechanism whereby the BM sustains its own plasticity through paracrine and endocrine actions of a unique adipokine.Funding: This work was supported by the National Institutes of Health T32DK007328 (NA), F31DK124926 (NA), R01DK121140 (JCL), R01AR068970 (BZ), R01AR071463 (BZ), R01DK112943 (LQ), R24DK092759 (CJR), and P01HL087123 (LQ).
- 22 June 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Open AccessAdipsin promotes bone marrow adiposity by priming mesenchymal stem cells
Background: Marrow adipose tissue (MAT) has been shown to be vital for regulating metabolism and maintaining skeletal homeostasis in the bone marrow (BM) niche. As a reflection of BM remodeling, MAT is highly responsive to nutrient fluctuations, hormonal changes, and metabolic disturbances such as obesity and diabetes mellitus. Expansion of MAT has also been strongly associated with bone loss in mice and humans. However, the regulation of BM plasticity remains poorly understood, as does the mechanism that links changes in marrow adiposity with bone remodeling.Methods: We studied deletion of Adipsin, and its downstream effector, C3, in C57BL/6 mice as well as the bone-protected PPARγ constitutive deacetylation 2KR mice to assess BM plasticity. The mice were challenged with thiazolidinedione treatment, calorie restriction, or aging to induce bone loss and MAT expansion. Analysis of bone mineral density and marrow adiposity was performed using a μCT scanner and by RNA analysis to assess adipocyte and osteoblast markers. For in vitro studies, primary bone marrow stromal cells were isolated and subjected to osteoblastogenic or adipogenic differentiation or chemical treatment followed by morphological and molecular analyses. Clinical data was obtained from samples of a previous clinical trial of fasting and high-calorie diet in healthy human volunteers.Results: We show that Adipsin is the most upregulated adipokine during MAT expansion in mice and humans in a PPARγ acetylation-dependent manner. Genetic ablation of Adipsin in mice specifically inhibited MAT expansion but not peripheral adipose depots, and improved bone mass during calorie restriction, thiazolidinedione treatment, and aging. These effects were mediated through its downstream effector, complement component C3, to prime common progenitor cells toward adipogenesis rather than osteoblastogenesis through inhibiting Wnt/β-catenin signaling.Conclusions: Adipsin promotes new adipocyte formation and affects skeletal remodeling in the BM niche. Our study reveals a novel mechanism whereby the BM sustains its own plasticity through paracrine and endocrine actions of a unique adipokine.Funding: This work was supported by the National Institutes of Health T32DK007328 (NA), F31DK124926 (NA), R01DK121140 (JCL), R01AR068970 (BZ), R01AR071463 (BZ), R01DK112943 (LQ), R24DK092759 (CJR), and P01HL087123 (LQ).
- Open Access
- 1 June 2021
- Published by Elsevier in STAR Protocols
- Vol. 2 (2) , 100397
Protocol for comprehensive RNA sequencing analysis of murine long non-coding RNAs during aging
- 1 June 2021
- Published by Elsevier in STAR Protocols
- Vol. 2 (2) , 100397
Open AccessProtocol for comprehensive RNA sequencing analysis of murine long non-coding RNAs during aging